Introduction
This symposium is the 6th meeting organized jointly between the Medicinal 91AV Section of the Swedish Academy of Pharmaceutical Sciences and the Biological and Medicinal 91AV Sector of the 91AV, to showcase the very best medicinal chemistry in a stimulating environment. It is also designed to provide plenty of opportunities to meet other delegates, renew friendships and foster new contacts. Please circulate this information widely around your networks.
Topics
The following will be covered: Kinases, GPCRs, Enzymes, protein-protein interactions, epigenetics, chemical biology, emerging target classes, as well as new interesting technologies within the field.
There will also be a poster session and we welcome abstracts for consideration.
For further details, see: www.lakemedelsakademin.se or email jenny.hagberg@lakemedelsakademin.se
Organizing committee
Dave Alker, David Alker Associates, UK
Adrian Hall, Eisai Ltd, UK
Carlos Garcia-Echeverria, Sanofi, France
Charles Hedgecock, Meira Life Science AB, Sweden
Kevin Dack, LEO Pharma, Denmark
Ed J Griffen, AstraZeneca R&D, UK
Thomas Hansson, AstraZeneca R&D, Sweden
Lilian Walther Jallow, Swedish Academy of Pharmaceutical Sciences, Sweden
This symposium is the 6th meeting organized jointly between the Medicinal 91AV Section of the Swedish Academy of Pharmaceutical Sciences and the Biological and Medicinal 91AV Sector of the 91AV, to showcase the very best medicinal chemistry in a stimulating environment. It is also designed to provide plenty of opportunities to meet other delegates, renew friendships and foster new contacts. Please circulate this information widely around your networks.
Topics
The following will be covered: Kinases, GPCRs, Enzymes, protein-protein interactions, epigenetics, chemical biology, emerging target classes, as well as new interesting technologies within the field.
There will also be a poster session and we welcome abstracts for consideration.
For further details, see: www.lakemedelsakademin.se or email jenny.hagberg@lakemedelsakademin.se
Organizing committee
Dave Alker, David Alker Associates, UK
Adrian Hall, Eisai Ltd, UK
Carlos Garcia-Echeverria, Sanofi, France
Charles Hedgecock, Meira Life Science AB, Sweden
Kevin Dack, LEO Pharma, Denmark
Ed J Griffen, AstraZeneca R&D, UK
Thomas Hansson, AstraZeneca R&D, Sweden
Lilian Walther Jallow, Swedish Academy of Pharmaceutical Sciences, Sweden
